Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Benzinga · 3d ago
Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $53 price target.